Skip to Content
Merck
All Photos(1)

Documents

880230P

Avanti

18:1 PEG5000 PE

Avanti Polar Lipids 880230P, powder

Synonym(s):

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt)

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

CAS Number:
474922-90-2
UNSPSC Code:
12352211
NACRES:
NA.25

form

powder

packaging

pkg of 2 × 100 mg (880230P-200mg)
pkg of 1 × 25 mg (880230P-25mg)

manufacturer/tradename

Avanti Polar Lipids 880230P

shipped in

dry ice

storage temp.

−20°C

SMILES string

[H][C@@](COP([O-])(OCCNC([(OCH2CH2)113OCH3])=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+]

Application

18:1 PEG5000 PE or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000 may be used in lipid bilayer preparation, and DOX free base loaded mixed dendrimer micelles (MDM DOX) preparation for tumor targeted delivery of siRNA and drugs.

Biochem/physiol Actions

18:1 PEG5000 PE, also referred as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (PEG5k-DOPE) in combination with lipid modified dendrimer copolymer supports co-delivery of siRNA and drugs to tumors.

Packaging

5 mL Clear Glass Sealed Ampule (880230P-200mg)
5 mL Clear Glass Sealed Ampule (880230P-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

No data available

Flash Point(C)

No data available

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

TCR--pMHC bond conformation controls TCR ligand discrimination
Sasmal DK, et al.
Cellular & Molecular Immunology (2019)
Xiaozheng Xu et al.
The Journal of cell biology, 219(6) (2020-05-22)
Blockade antibodies of the immunoinhibitory receptor PD-1 can stimulate the anti-tumor activity of T cells, but clinical benefit is limited to a fraction of patients. Evidence suggests that BTLA, a receptor structurally related to PD-1, may contribute to resistance to

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service